{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:25:11Z","timestamp":1793967911078,"version":"4.8.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":244,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270581"],"award-info":[{"award-number":["82270581"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["Baoan District Medical and Health Scientific Research Project of Shenzhen City"],"award-info":[{"award-number":["Baoan District Medical and Health Scientific Research Project of Shenzhen City"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.clinsp.2026.101139","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:15:05Z","timestamp":1789071305000},"page":"101139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Efficacy and safety of live combined Bacillus subtilis and Enterococcus faecium in patients with Helicobacter pylori infection: A meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1571-8329","authenticated-orcid":false,"given":"Chenghai","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9740-0827","authenticated-orcid":false,"given":"Bingyun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1107-1798","authenticated-orcid":false,"given":"Cangui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1895-8515","authenticated-orcid":false,"given":"Anjiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5203-6616","authenticated-orcid":false,"given":"Ye","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clinsp.2026.101139_bib0001","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41572-023-00431-8","article-title":"Helicobacter pylori infection","volume":"9","author":"Malfertheiner","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.clinsp.2026.101139_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1257817","article-title":"Helicobacter pylori infection: a dynamic process from diagnosis to treatment","volume":"13","author":"Sun","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"10.1016\/j.clinsp.2026.101139_bib0003","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000519413","article-title":"The ideal Helicobacter pylori treatment for the present and the future","volume":"103","author":"Suzuki","year":"2022","journal-title":"Digestion"},{"issue":"9","key":"10.1016\/j.clinsp.2026.101139_bib0004","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.14309\/ajg.0000000000002968","article-title":"ACG clinical guideline: treatment of Helicobacter pylori infection","volume":"119","author":"Chey","year":"2024","journal-title":"Am J Gastroenterol"},{"issue":"14","key":"10.1016\/j.clinsp.2026.101139_bib0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411708","article-title":"Antibiotic Resistance, Susceptibility Testing and Stewardship in Helicobacter pylori Infection","volume":"24","author":"Ng","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.clinsp.2026.101139_bib0006","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00258-21","article-title":"Helicobacter pylori infection, its laboratory diagnosis, and antimicrobial resistance: a perspective of clinical relevance","volume":"35","author":"Ansari","year":"2022","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"10.1016\/j.clinsp.2026.101139_bib0007","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1080\/10408398.2020.1843396","article-title":"Antibiotic-induced gut dysbiosis and barrier disruption and the potential protective strategies","volume":"62","author":"Duan","year":"2022","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10.1016\/j.clinsp.2026.101139_bib0008","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jare.2024.06.006","article-title":"Prevention and treatment of antibiotics-associated adverse effects through the use of probiotics: a review","volume":"71","author":"Yang","year":"2025","journal-title":"J Adv Res"},{"key":"10.1016\/j.clinsp.2026.101139_bib0009","article-title":"Helicobacter pylori infection in humans and phytotherapy, probiotics, and emerging therapeutic interventions: a review","volume":"14","author":"Liu","year":"2023","journal-title":"Front Microbiol"},{"key":"10.1016\/j.clinsp.2026.101139_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.938608","article-title":"Relationship between Helicobacter pylori infection and gastrointestinal microecology","volume":"12","author":"Xu","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.clinsp.2026.101139_bib0011","doi-asserted-by":"crossref","DOI":"10.1093\/femsle\/fnad118","article-title":"Enterococcus faecium R-026 combined with Bacillus subtilis R-179 alleviate hypercholesterolemia and modulate the gut microbiota in C57BL\/6 mice","volume":"370","author":"Huang","year":"2023","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.clinsp.2026.101139_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.1005842","article-title":"Oral administration of live combined Bacillus subtilis and Enterococcus faecium alleviates colonic oxidative stress and inflammation in osteoarthritic rats by improving fecal microbiome metabolism and enhancing the colonic barrier","volume":"13","author":"Tang","year":"2022","journal-title":"Front Microbiol"},{"issue":"5","key":"10.1016\/j.clinsp.2026.101139_bib0013","first-page":"542","article-title":"Impact of probiotics on anti-Helicobacter pylori therapy","volume":"38","author":"Liu","year":"2009","journal-title":"Chongqing Med"},{"issue":"22","key":"10.1016\/j.clinsp.2026.101139_bib0014","first-page":"1991","article-title":"Efficacy analysis of Probiotics combined with triple therapy for Helicobacter pylori infection","volume":"27","author":"Zhang","year":"2012","journal-title":"Clin Focus"},{"issue":"23","key":"10.1016\/j.clinsp.2026.101139_bib0015","first-page":"125","article-title":"Efficacy of Mei Chang an capsules for Helicobacter pylori eradication","author":"Hu","year":"2013","journal-title":"J Med Inf"},{"issue":"9","key":"10.1016\/j.clinsp.2026.101139_bib0016","first-page":"1055","article-title":"Efficacy of two probiotics in the eradication of Helicobacter pylori","author":"Duan","year":"2014","journal-title":"Clin Focus"},{"issue":"20","key":"10.1016\/j.clinsp.2026.101139_bib0017","first-page":"8","article-title":"Effect observation of quadruple therapy combined with Medilac-S to eradicate Helicobacter pylori","author":"He","year":"2014","journal-title":"Chin J Clin Ration Drug Use"},{"issue":"19","key":"10.1016\/j.clinsp.2026.101139_bib0018","first-page":"350","article-title":"Efficacy of Meichangan in the treatment of Helicobacter pylori-related peptic ulcer","author":"Jiang","year":"2014","journal-title":"J Med Inf"},{"issue":"5","key":"10.1016\/j.clinsp.2026.101139_bib0019","first-page":"52","article-title":"Clinical observation of enteric capsules of bigeminy living Bacillus subtilis and quadruple therapy in treatment of Helicobacter pylori infections in the elderly","author":"Du","year":"2015","journal-title":"Prog Microbiol Immunol"},{"issue":"16","key":"10.1016\/j.clinsp.2026.101139_bib0020","first-page":"54","article-title":"The efficacy of quadruple therapy and live combined Bacillus subtilis enteric-coated capsules in the treatment of Helicobacter pylori-positive peptic ulcer","volume":"6","author":"Zhang","year":"2015","journal-title":"Chin Manip Rehabil Med"},{"issue":"20","key":"10.1016\/j.clinsp.2026.101139_bib0021","first-page":"161","article-title":"Clinical control study on the eradication of Helicobacter pylori infection by combination of Bacillus subtilis two live bacteria capsules and triple therapy","volume":"8","author":"Cui","year":"2016","journal-title":"China Contin Med Educ"},{"issue":"3","key":"10.1016\/j.clinsp.2026.101139_bib0022","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/hel.12270","article-title":"The effect of probiotics on gut microbiota during the Helicobacter pylori eradication: randomized controlled trial","volume":"21","author":"Oh","year":"2016","journal-title":"Helicobacter"},{"issue":"1","key":"10.1016\/j.clinsp.2026.101139_bib0023","first-page":"20","article-title":"Effects of probiotics combined with quadruple therapy in treatment of Helicobacter pylori infection","volume":"28","author":"Xu","year":"2016","journal-title":"Chin J Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.clinsp.2026.101139_bib0024","first-page":"91","article-title":"Clinical efficacy of live combined Bacillus subtilis and enterogenous capsules combined with bismuth quadruple therapy in the treatment of duodenal ulcer","volume":"57","author":"Luo","year":"2017","journal-title":"Shandong Med J"},{"issue":"9","key":"10.1016\/j.clinsp.2026.101139_bib0025","first-page":"1038","article-title":"Clinical efficacy of Bacillus subtilis combined with standard triple therapy for Helicobacter pylori infection","volume":"26","author":"Wang","year":"2017","journal-title":"Chin J New Drugs"},{"issue":"11","key":"10.1016\/j.clinsp.2026.101139_bib0026","first-page":"136","article-title":"Effect of Meichangan combined with bismuth quadruple therapy on Helicobacter pylori infection in elderly patients with peptic ulcer","author":"Zhou","year":"2017","journal-title":"China High Med Educ"},{"issue":"4","key":"10.1016\/j.clinsp.2026.101139_bib0027","first-page":"258","article-title":"Curative efficacy of Bacillus subtilis combined with quadruple therapy in treatment of Helicobacter pylori infection in the elderly","volume":"38","author":"Chen","year":"2018","journal-title":"Int J Dig Dis"},{"issue":"2","key":"10.1016\/j.clinsp.2026.101139_bib0028","first-page":"160","article-title":"Evaluation of therapeutic efficiency of Medilac-S in rescue eradication therapy for Helicobacter pylori infection","volume":"27","author":"Jin","year":"2018","journal-title":"Chin J Gastroenterol Hepatol"},{"issue":"23","key":"10.1016\/j.clinsp.2026.101139_bib0029","first-page":"157","article-title":"The efficacy of live Bacillus subtilis combined with bismuth quadruple therapy in the treatment of DU","volume":"28","author":"Xue","year":"2018","journal-title":"Shenzhen J Integr Tradit Chin West Med"},{"issue":"3","key":"10.1016\/j.clinsp.2026.101139_bib0030","first-page":"24","article-title":"Clinical efficacy of live combined Bacillus subtilis and enterogenous capsules combined with bismuth quadruple therapy in the treatment of duodenal ulcer","volume":"18","author":"Zhang","year":"2018","journal-title":"Pr Clin J Integr Tradit Chin West Med"},{"issue":"3","key":"10.1016\/j.clinsp.2026.101139_bib0031","first-page":"70","article-title":"The effect of Meichangan on eradication rate and adverse reactions in the treatment of Helicobacter pylori","volume":"19","author":"Chen","year":"2019","journal-title":"Pr Clin J Integr Tradit Chin West Med"},{"issue":"1","key":"10.1016\/j.clinsp.2026.101139_bib0032","article-title":"Effects of anti-H. pylori triple therapy and a probiotic complex on intestinal microbiota in duodenal ulcer","volume":"9","author":"Wu","year":"2019","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.clinsp.2026.101139_bib0033","first-page":"1243","article-title":"Effect of live combined Bacillus subtilis and Bacillus subtilis enteric-coated capsules in the adjuvant treatment of H. pylori-positive duodenal ulcer","author":"Ye","year":"2019","journal-title":"Chronic Pathematol J"},{"issue":"6","key":"10.1016\/j.clinsp.2026.101139_bib0034","first-page":"463","article-title":"The efficacy of live combined Bacillus subtilis and Bacillus subtilis enteric-coated capsules in the adjuvant treatment of H. pylori-positive duodenal ulcer","volume":"15","author":"Chang","year":"2021","journal-title":"J Dis Monit Control"},{"issue":"10","key":"10.1016\/j.clinsp.2026.101139_bib0035","first-page":"122","article-title":"Effect of Bacillus subtilis combined with triple therapy in treatment of Helicobacter pylori infection in children","volume":"1","author":"Zhao","year":"2022","journal-title":"J Women Child Health Guide"},{"issue":"5","key":"10.1016\/j.clinsp.2026.101139_bib0036","first-page":"76","article-title":"The clinical effect of probiotics in the treatment of Helicobacter pylori infection and its influence on intestinal microecology","volume":"17","author":"Li","year":"2024","journal-title":"Chin J Clin Ration Drug Use"},{"issue":"6","key":"10.1016\/j.clinsp.2026.101139_bib0037","first-page":"920","article-title":"Efficacy of live combined Bacillus subtilis and Enterococcus faecium combined with bismuth-containing quadruple therapy for Helicobacter pylori infection and its impacts on serum inflammatory factors","volume":"13","author":"Li","year":"2024","journal-title":"Transl Med J"},{"issue":"10","key":"10.1016\/j.clinsp.2026.101139_bib0038","first-page":"2447","article-title":"The effect of high-dose binary therapy eradication of H. pylori on intestinal microecology and the corresponding probiotic intervention effect","volume":"45","author":"Lin","year":"2024","journal-title":"Jilin Med J"},{"key":"10.1016\/j.clinsp.2026.101139_bib0039","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ (Clin res ed)"},{"key":"10.1016\/j.clinsp.2026.101139_bib0040","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.clinsp.2026.101139_bib0041","article-title":"The interactions between oral-gut axis microbiota and Helicobacter pylori","volume":"12","author":"Chen","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"10.1016\/j.clinsp.2026.101139_bib0042","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","article-title":"Management of Helicobacter pylori infection-the Maastricht V\/Florence Consensus Report","volume":"66","author":"Malfertheiner","year":"2017","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.clinsp.2026.101139_bib0043","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2018.07.007","article-title":"Prevalence of antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis in World Health Organization regions","volume":"155","author":"Savoldi","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinsp.2026.101139_bib0044","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.1042070","article-title":"Current and future perspectives for Helicobacter pylori treatment and management: from antibiotics to probiotics","volume":"12","author":"Liang","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"15","key":"10.1016\/j.clinsp.2026.101139_bib0045","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000015180","article-title":"Efficacy and safety of probiotics in eradicating Helicobacter pylori: a network meta-analysis","volume":"98","author":"Shi","year":"2019","journal-title":"Med (Baltim)"},{"issue":"4","key":"10.1016\/j.clinsp.2026.101139_bib0046","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.clinre.2017.04.004","article-title":"Probiotics in Helicobacter pylori eradication therapy: systematic review and network meta-analysis","volume":"41","author":"Wang","year":"2017","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.clinsp.2026.101139_bib0047","article-title":"Comparative effectiveness of different probiotics supplements for triple helicobacter pylori eradication: a network meta-analysis","volume":"13","author":"Wang","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.clinsp.2026.101139_bib0048","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.clnesp.2024.11.016","article-title":"Efficacy of probiotics regimens for Helicobacter pylori eradication: a systematic review, pairwise, and network meta-analysis of randomized controlled trials","volume":"65","author":"Tanashat","year":"2025","journal-title":"Clin Nutr ESPEN"},{"issue":"12","key":"10.1016\/j.clinsp.2026.101139_bib0049","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/s00203-022-03314-w","article-title":"The impacts of probiotics in eradication therapy of Helicobacter pylori","volume":"204","author":"Bai","year":"2022","journal-title":"Arch Microbiol"},{"issue":"2","key":"10.1016\/j.clinsp.2026.101139_bib0050","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4014\/jmb.2009.09005","article-title":"Enterococcus faecium R0026 combined with bacillus subtilis R0179 prevent obesity-associated hyperlipidemia and modulate gut microbiota in C57BL\/6 mice","volume":"31","author":"Huang","year":"2021","journal-title":"J Microbiol Biotechnol"},{"key":"10.1016\/j.clinsp.2026.101139_bib0051","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.821662","article-title":"Effects of live combined bacillus subtilis and enterococcus faecium on gut microbiota composition in C57BL\/6 mice and in humans","volume":"12","author":"Pi","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"10","key":"10.1016\/j.clinsp.2026.101139_bib0052","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223309","article-title":"Efficacy of Lactobacillus-supplemented triple therapy for H. pylori eradication: a meta-analysis of randomized controlled trials","volume":"14","author":"Yu","year":"2019","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.clinsp.2026.101139_bib0053","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1523-5378.2009.00716.x","article-title":"Meta-analysis: lactobacillus containing quadruple therapy versus standard triple first-line therapy for Helicobacter pylori eradication","volume":"14","author":"Zou","year":"2009","journal-title":"Helicobacter"},{"issue":"19","key":"10.1016\/j.clinsp.2026.101139_bib0054","doi-asserted-by":"crossref","first-page":"5583","DOI":"10.3748\/wjg.v20.i19.5583","article-title":"Immune responses to Helicobacter pylori infection","volume":"20","author":"Moyat","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.clinsp.2026.101139_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2024.189139","article-title":"Helicobacter pylori triggers inflammation and oncogenic transformation by perturbing the immune microenvironment","volume":"1879","author":"Wang","year":"2024","journal-title":"Biochim Biophys Acta Rev Cancer"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593226002668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593226002668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T11:32:54Z","timestamp":1793964774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593226002668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":55,"alternative-id":["S1807593226002668"],"URL":"https:\/\/doi.org\/10.1016\/j.clinsp.2026.101139","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of live combined Bacillus subtilis and Enterococcus faecium in patients with Helicobacter pylori infection: A meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinsp.2026.101139","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 HCFMUSP. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"101139"}}